Ms. Shrimanti Chakraborty, Birla Institute of Technology, Mesra , India
Shrimanti Chakraborty is a dedicated aspiring research scientist in the field of Medicinal Chemistry. Currently pursuing a Master of Pharmacy in Pharmaceutical Chemistry at Birla Institute of Technology, Mesra, India, she is passionate about advancing pharmaceutical solutions that impact human health. With a solid academic foundation, she has contributed to research on green synthesis of nanoparticles and novel antimicrobial compounds. She has also gained valuable industry experience through internships and research projects, such as her work on molecular docking studies and drug discovery. As a dedicated student leader, Shrimanti holds various academic and extracurricular positions, contributing to her professional growth and development in scientific fields.
Professional Profile:
Google Scholar
Summary of Suitability for Award:
Shrimanti Chakraborty is a highly qualified and accomplished researcher with a strong track record in academic achievements, publications, and practical experience. Her research in medicinal chemistry, combined with her leadership skills and industry exposure, makes her an excellent candidate for the Best Researcher Award. Her contributions to the scientific community are poised to make a significant impact, showcasing her as an emerging leader in the field.
🎓Education:
Shrimanti Chakraborty completed her Bachelor of Pharmacy (BPharm) with 93.4% from Birla Institute of Technology, Mesra, in 2023. Currently, she is pursuing a Master of Pharmacy (MPharm) in Pharmaceutical Chemistry at the same institution, where she has secured an impressive 92.9%. Her academic foundation is strengthened by high achievements, including 94.75% in Higher Secondary and 94.8% in Matriculation, both from St. Joseph’s Convent, Chandannagar. Throughout her education, she has consistently displayed excellence in both theoretical knowledge and practical skills, focusing on pharmaceutical sciences, organic synthesis, and medicinal chemistry.
🏢Work Experience:
Shrimanti has gained invaluable professional experience through internships and industrial training. She worked at Dr. Reddy’s Laboratories, Hyderabad, contributing to clinical trial analysis and reporting. As part of the Khorana Program for Scholars, she interned at Purdue University, USA, under IUSSTF, gaining exposure to global pharmaceutical research. Additionally, Shrimanti participated in the Molecular Biology and Biochemistry Techniques program at IIT Kharagpur and Mendine Pharmaceuticals Pvt. Ltd. She is also involved in ongoing research projects, including her MPharm thesis on novel imidazole analogues. Her hands-on expertise includes computational modeling, molecular docking, and synthetic organic chemistry.
🏅Awards:
Shrimanti has earned recognition for her academic and professional achievements. She won the 1st prize along with a cash prize of INR 10,000 in the Flash Talk Competition at the International Symposium on Nucleic Acids Research by NIPER Kolkata. Her excellence in Mathematics ISC 2019 earned her rank 1, while in WIZ National Spell Bee 2014-15, she secured rank 2 and was honored with a cash prize. She also achieved rank 47 in the State Level Grand Finale of WIZ National Spell Bee. These accomplishments highlight her commitment to academic excellence, public speaking, and leadership in scientific endeavors.
🔬Research Focus:
Shrimanti’s research primarily focuses on Medicinal Chemistry, specifically in areas like molecular docking, drug design, and pharmacology. She has worked on green synthesis of iron/iron oxide nanoparticles, novel antimicrobial agents, and molecular dynamics. Her ongoing work includes imidazole analogues with potential antimicrobial activity, and phytoconstituents docking studies targeting Parkinson’s disease. She utilizes advanced computational techniques such as HTVS, AutoDock, Schrodinger, and Desmond for structure-based drug design. Her aim is to contribute to the development of innovative pharmaceutical solutions for treating chronic diseases and improving human health.
Publication Top Notes:
-
Fundamental approaches of drug discovery
-
Comparative Molecular Docking Studies of Selected Phytoconstituents on the Dopamine D3 Receptor (PDB ID: 3PBL) as Potential Anti-Parkinson’s Agents